Michael Brian Bell's Insider Trades & SAST Disclosures
Michael Brian Bell's most recent trade in Guardant Health Inc was a trade of 2,084 Restricted Stock Units done . Disclosure was reported to the exchange on April 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael Brian Bell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,084 | 12,505 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,084 | 41,445 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.47 per share. | 01 Apr 2025 | 1,057 | 40,388 (0%) | 0% | 42.5 | 44,891 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 2,039 | 10,195 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 2,039 | 41,020 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.89 per share. | 15 Mar 2025 | 1,659 | 39,361 (0%) | 0% | 42.9 | 71,155 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,233 | 38,981 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,233 | 4,932 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 33,498 | 33,498 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 22,332 | 22,332 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 7,108 | 14,220 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 7,108 | 40,285 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.55 per share. | 01 Mar 2025 | 2,537 | 37,748 (0%) | 0% | 42.5 | 107,949 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 6,617 | 35,538 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 6,617 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.98 per share. | 01 Feb 2025 | 2,361 | 33,177 (0%) | 0% | 47.0 | 110,920 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 3,309 | 30,226 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 3,309 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.50 per share. | 15 Jan 2025 | 1,305 | 28,921 (0%) | 0% | 37.5 | 48,938 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 2,084 | 27,772 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 2,084 | 14,589 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.55 per share. | 01 Jan 2025 | 855 | 26,917 (0%) | 0% | 30.5 | 26,120 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 2,039 | 12,234 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 2,039 | 27,347 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 15 Dec 2024 | 1,659 | 25,688 (0%) | 0% | 34.8 | 57,667 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 1,233 | 25,308 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 1,233 | 6,165 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 59,534 | 59,534 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 39,689 | 39,689 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 8,211 | 28,237 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 8,211 | 16,673 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.12 per share. | 01 Oct 2024 | 4,162 | 24,075 (0%) | 0% | 22.1 | 92,063 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 2,039 | 21,685 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 2,039 | 14,273 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.79 per share. | 15 Sep 2024 | 1,659 | 20,026 (0%) | 0% | 26.8 | 44,445 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 1,233 | 7,398 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 1,233 | 19,646 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 8,034 | 16,312 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 8,034 | 21,720 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.21 per share. | 15 Jun 2024 | 3,307 | 18,413 (0%) | 0% | 30.2 | 99,904 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 1,233 | 13,686 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 1,233 | 8,631 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 1,233 | 9,864 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 1,233 | 12,882 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.74 per share. | 15 Mar 2024 | 429 | 12,453 (0%) | 0% | 17.7 | 7,610 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 3,308 | 3,309 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Brian Michael Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 3,308 | 13,005 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.20 per share. | 15 Jan 2024 | 1,356 | 11,649 (0%) | 0% | 24.2 | 32,815 | COMMON STOCK |
| Guardant Health Inc | Brian Bell Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 1,233 | 11,097 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 1,233 | 10,124 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Brian Michael Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.19 per share. | 15 Dec 2023 | 427 | 9,697 (0%) | 0% | 28.2 | 12,037 | COMMON STOCK |
| Guardant Health Inc | Brian Bell Michael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 37,326 | 37,326 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Michael Bell Brian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 24,884 | 24,884 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 1,233 | 13,563 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 1,233 | 8,512 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.86 per share. | 15 Jun 2023 | 427 | 8,085 (0%) | 0% | 37.9 | 16,166 | COMMON STOCK |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 36,519 | 36,519 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 24,346 | 24,346 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 4,931 | 14,796 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 4,931 | 8,982 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.78 per share. | 15 Mar 2023 | 1,703 | 7,279 (0%) | 0% | 26.8 | 45,606 | COMMON STOCK |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 3,309 | 5,371 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 3,309 | 6,617 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.43 per share. | 15 Jan 2023 | 1,320 | 4,051 (0%) | 0% | 30.4 | 40,168 | COMMON STOCK |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 39,454 | 39,454 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 19,727 | 19,727 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2022 | 3,308 | 9,926 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 3,308 | 3,308 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.58 per share. | 15 Jan 2022 | 1,246 | 2,062 (0%) | 0% | 77.6 | 96,665 | COMMON STOCK |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 26,467 | 26,467 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Michael Brian Bell | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 13,234 | 13,234 | - | - | RESTRICTED STOCK UNITS | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 48.15 per share. | 03 Nov 2020 | 32,574 | 103,343 (0%) | 0% | 48.2 | 1,568,487 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 12,667 | 19,333 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.17 per share. | 03 Nov 2020 | 12,667 | 126,277 (0%) | 0% | 27.2 | 344,162 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 4,167 | 21,875 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.24 per share. | 03 Nov 2020 | 4,167 | 131,612 (0%) | 0% | 12.2 | 51,004 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 3,750 | 13,125 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.90 per share. | 03 Nov 2020 | 3,750 | 135,362 (0%) | 0% | 5.9 | 22,125 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 03 Nov 2020 | 3,333 | 113,610 (0%) | 0% | 1 | 3,333 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 3,333 | 6,667 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 1,168 | 4,963 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.31 per share. | 03 Nov 2020 | 1,168 | 127,445 (0%) | 0% | 6.3 | 7,370 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 555 | 1,667 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.80 per share. | 03 Nov 2020 | 555 | 135,917 (0%) | 0% | 2.8 | 1,554 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.65 per share. | 06 Aug 2020 | 619 | 110,277 (0%) | 0% | 34.6 | 21,448 | Common Stock |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2020 | 40,000 | 110,896 (0%) | 0% | 0 | Common Stock | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2020 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 01 Jun 2020 | 6,197 | 70,896 (0%) | 0% | 32.8 | 203,386 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges